IBC Life Sciences, Hilton Boston Logan Airport, Boston, MA
June 6-8, 2005
IBC’s Evaluating Preclinical Drug Safety will review in vitro, in vivo, and in silico approaches to predicting drug safety. Hear from experts from Eli Lilly, Abbott Laboratories, AstraZeneca, F.Hoffmann-La Roche, Ltd., Novartis Institutes for Biomedical Research, the FDA’s National Center for Toxicological Research and more. As a registered attendee for the Evaluating Preclinical Drug Safety conference, you will be able to attend the co-located Early Efficacy Assessment conferences at no charge! To register or view full details, visit www.IBCLifeSciences.com/3141 or call +1 508-616-5550 x1004.
|
|